FOR SERIOUS TRADERS

Build a trading process you can defend.

You own decisions, psychology and risk. Ainstein owns strategy research, WFO validation and usable indicators.

Start the Trader Path View Products

STRATEGY vs the unlevered S&P 500 price index, 2005-03-15 to 2026-06-26. Both are indexed to 100 on the first common date and shown on a log scale. STRATEGY includes modelled commissions and slippage, but excludes financing interest, dividends, taxes, and additional market impact. Hypothetical research; not a risk-equivalent comparison.

A strong fit

You treat trading as a process.

You write rules and risk boundaries
You accept uncertainty in tests and live markets
You record, execute and review consistently

Not a fit

You only want the next signal.

You expect guaranteed returns or no drawdown
You treat product states as personalised orders
You retune or replace a system after each loss

Six stages. Two clear responsibilities.

Ainstein owns Define, Test and Validate. You own Execute, Review and Adapt.

AINSTEIN / WEAPONDefine

Specify what the weapon is allowed to do.

A versioned research specification with explicit product boundaries.

AINSTEIN / WEAPONTest

Challenge the research hypothesis.

An auditable test record with measurable acceptance criteria.

AINSTEIN / WEAPONValidate

Make unseen evidence earn the release.

A documented release decision and public Validation Passport boundary.

TRADER / HOW YOU USE ITExecute

Use the product inside a written risk plan.

A repeatable pre-trade and execution routine inside your risk budget.

TRADER / HOW YOU USE ITReview

Review decisions, not only P&L.

A journal that separates execution quality from outcome noise.

TRADER / HOW YOU USE ITAdapt

Change your use only when evidence justifies it.

A controlled keep, reduce or pause decision without reactive retuning.

View the complete Trader Path

PRODUCTS

We build the weapons. You are responsible for using them correctly.

Every product publishes its market, timeframe, process role, version, health and primary limits.

TSLA

TSLA Intraday Flow

Timeframe: Standard 1 minute
Session: U.S. RTH
Process role: execute

Airv1.0.0Under Review

Prov2.1.0Under Review

In-sampleComplete

Walk-forward OOSComplete

Monte CarloNot public

Release monitoringComplete

NQ / MNQ / QQQ

NASDAQ Intraday Flow

Timeframe: Standard 1 minute
Session: U.S. RTH
Process role: execute

Airv1.0.0Under Review

Prov2.0.0Under Review

In-sampleComplete

Walk-forward OOSComplete

Monte CarloNot public

Release monitoringComplete

NASDAQ-100

Ainstein TECH Momentum 10

Timeframe: Monthly
Session: Monthly release
Process role: execute

Prov1.0.0Under Review

In-sampleNot public

Walk-forward OOSNot public

Monte CarloNot public

Release monitoringComplete

View all Products

Each validation step reduces a different error.

IS

Build a bounded research hypothesis

Walk-forward OOS

Test unseen data in time order

Monte Carlo

Inspect path and drawdown uncertainty

Release Monitoring

Monitor version and product health

Read the full methodology

Start with the stage you are in.

Market context vs. trading signal.

INTERPRETATION BOUNDARY Test

Expectancy needs a distribution, not a win rate.

TEST THE CLAIM Validate

What out-of-sample validation can and cannot tell you.

VALIDATION FOUNDATION Execute

Build a trading plan that can survive the next decision.

DEFINE YOUR PROCESS Review

A trading journal should audit decisions, not decorate P&L.

REVIEW THE DECISION Adapt

Pause a strategy with rules, not with panic.

ADAPT WITH EVIDENCE

Start with your trading process.

The Trader Path is public. When you need a tool, choose it through its Validation Passport.

Start the Trader Path Get Air free